How to Master Compliance in an Evolving Regulatory, Technology and Patient Environment
- kimabc2112
- Jan 22
- 1 min read
Medical and commercial partnerships continue to be a topic consideration for Medical
Affairs teams, especially prior to drug approval. At a workshop at the March MAPS
meeting in Denver, this will be the topic covered during a workshop hosted by the
Medical Governance & Compliance Domain.
I suspect we agree that these partnerships are important and beneficial as each team
brings something important to the conversation, but where is a safe space to work
together?
What example can you give for ways to partner prelaunch?
What opportunities have you deemed too risky for partnership?
What questions remain for you?
Join in the discussion at the upcoming MAPS meeting. Can’t attend the meeting in
Denver? Please share your perspective here so we can discuss them in one of the
many other forums MAPS offers.
